PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2025/68 - Giuliani / Grupo Laboratoires Bailleul
Acquiring
Giuliani S.p.A.
Description
An Italian-registered company focused on the development, manufacture, and marketing of pharmaceuticals, medical devices, dermocosmetic products, and dietary supplements. In Portugal, Giuliani operates exclusively in the dietary supplement and dermocosmetic product segments.
Acquired
Laboratoires Bailleul International S.A.
Description
A Swiss-based company, the controlling company of the so-called Laboratoires Bailleul Group. The Laboratoires Bailleul Group has a presence in several countries, and its Portuguese subsidiary, Laboratoires Bailleul Portugal S.A., included in the transaction, is a pharmaceutical company dedicated to the development and marketing of medicines, dietary supplements, and dermocosmetic products.
Sector
Activity (NACE)
Applicable legislation
Notification thresholds
Type of merger
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

The concentration transaction consists of the acquisition, by Giuliani S.p.A (“Giuliani”) of exclusive control of the entire share capital of Laboratoires Bailleul International S.A (“Bailleul”), through the acquisition of its entire share capital.
Timeline
2025-09-10
Phase I Decision - AdC adopted a non-opposition decision in concentration operation 68/2025 - Giuliani / Grupo Laboratoires Bailleul.
2025-08-21
Giuliani notifies the acquisition of sole control over the Laboratoires Bailleul Group.
Click here to see your activities